Kodal B - Search Results

1

Early assessment of dosimetric and biological differences of total marrow irradiation versus total body irradiation in rodents.

Hui S, Takahashi Y, Holtan SG, Azimi R, Seelig D, Yagi M, Ingvalson J, Alaei P, Sharkey L, Kodal B, Peterson N, Meyer C, Godin L, Ehrhardt M, Storme G, Zhou D, Panoskaltsis-Mortari A. Hui S, et al. Among authors: kodal b. Radiother Oncol. 2017 Sep;124(3):468-474. doi: 10.1016/j.radonc.2017.07.018. Epub 2017 Aug 1. Radiother Oncol. 2017. PMID: 28778346 Free PMC article.

2

Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.

Uppendahl LD, Felices M, Bendzick L, Ryan C, Kodal B, Hinderlie P, Boylan KLM, Skubitz APN, Miller JS, Geller MA. Uppendahl LD, et al. Among authors: kodal b. Gynecol Oncol. 2019 Apr;153(1):149-157. doi: 10.1016/j.ygyno.2019.01.006. Epub 2019 Jan 15. Gynecol Oncol. 2019. PMID: 30658847 Free PMC article.

3

IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer.

Felices M, Chu S, Kodal B, Bendzick L, Ryan C, Lenvik AJ, Boylan KLM, Wong HC, Skubitz APN, Miller JS, Geller MA. Felices M, et al. Among authors: kodal b. Gynecol Oncol. 2017 Jun;145(3):453-461. doi: 10.1016/j.ygyno.2017.02.028. Epub 2017 Feb 22. Gynecol Oncol. 2017. PMID: 28236454 Free PMC article.

4

TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity.

Kaminski MF, Bendzick L, Hopps R, Kauffman M, Kodal B, Soignier Y, Hinderlie P, Walker JT, Lenvik TR, Geller MA, Miller JS, Felices M. Kaminski MF, et al. Among authors: kodal b. J Immunother Cancer. 2022 Sep;10(9):e004725. doi: 10.1136/jitc-2022-004725. J Immunother Cancer. 2022. PMID: 36162918 Free PMC article.

5

Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager.

Felices M, Lenvik TR, Kodal B, Lenvik AJ, Hinderlie P, Bendzick LE, Schirm DK, Kaminski MF, McElmurry RT, Geller MA, Eckfeldt CE, Vallera DA, Miller JS. Felices M, et al. Among authors: kodal b. Cancer Immunol Res. 2020 Sep;8(9):1139-1149. doi: 10.1158/2326-6066.CIR-19-0837. Epub 2020 Jul 13. Cancer Immunol Res. 2020. PMID: 32661096 Free PMC article.

6

Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL.

Felices M, Kodal B, Hinderlie P, Kaminski MF, Cooley S, Weisdorf DJ, Vallera DA, Miller JS, Bachanova V. Felices M, et al. Among authors: kodal b. Blood Adv. 2019 Mar 26;3(6):897-907. doi: 10.1182/bloodadvances.2018029371. Blood Adv. 2019. PMID: 30890546 Free PMC article.

7

NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo.

Vallera DA, Ferrone S, Kodal B, Hinderlie P, Bendzick L, Ettestad B, Hallstrom C, Zorko NA, Rao A, Fujioka N, Ryan CJ, Geller MA, Miller JS, Felices M. Vallera DA, et al. Among authors: kodal b. Cancers (Basel). 2020 Sep 18;12(9):2659. doi: 10.3390/cancers12092659. Cancers (Basel). 2020. PMID: 32961861 Free PMC article.

8

A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer.

Vallera DA, Oh F, Kodal B, Hinderlie P, Geller MA, Miller JS, Felices M. Vallera DA, et al. Among authors: kodal b. Cancers (Basel). 2021 Aug 8;13(16):3994. doi: 10.3390/cancers13163994. Cancers (Basel). 2021. PMID: 34439149 Free PMC article.

9

Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy.

Woan KV, Kim H, Bjordahl R, Davis ZB, Gaidarova S, Goulding J, Hancock B, Mahmood S, Abujarour R, Wang H, Tuininga K, Zhang B, Wu CY, Kodal B, Khaw M, Bendzick L, Rogers P, Ge MQ, Bonello G, Meza M, Felices M, Huffman J, Dailey T, Lee TT, Walcheck B, Malmberg KJ, Blazar BR, Bryceson YT, Valamehr B, Miller JS, Cichocki F. Woan KV, et al. Among authors: kodal b. Cell Stem Cell. 2021 Dec 2;28(12):2062-2075.e5. doi: 10.1016/j.stem.2021.08.013. Epub 2021 Sep 14. Cell Stem Cell. 2021. PMID: 34525347 Free PMC article.

10

Allogeneic NK cells eradicate myeloblasts but not neoplastic mast cells in systemic mastocytosis associated with acute myeloid leukemia.

Ustun C, Williams S, Skendzel S, Kodal B, Arock M, Gotlib J, Vallera DA, Cooley S, Felices M, Weisdorf D, Miller J. Ustun C, et al. Among authors: kodal b. Am J Hematol. 2017 May;92(5):E66-E68. doi: 10.1002/ajh.24673. Epub 2017 Feb 24. Am J Hematol. 2017. PMID: 28187525 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters